Akron to collaborate with Vor Bio on nucleases

By The Science Advisory Board staff writers

March 24, 2022 -- Akron BioProducts and Vor Bio have announced an agreement to develop and manufacture current good manufacturing practice nucleases.

The collaboration strengthens Akron's portfolio of off-the-shelf gene editing technologies and broadens Vor Bio's collection of nucleases to engineer gene modified cell therapies, the companies said.

The collaboration also will focus on developing and manufacturing starting materials needed to advance potential treatments for blood cancers, the companies said.


Copyright © 2022 scienceboard.net
 


Email Address:

First Name:

Last Name:

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.